Next Quarterly Earnings
After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
Editas Medicine is a leading US-based biotechnology company specializing in the development of innovative gene therapies. Utilizing CRISPR gene-editing technology, the company researches transformative treatment methods for serious genetic diseases to improve patient outcomes through precision medicine.
After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
Editas Medicine is scheduled to report its next quarterly earnings on 11/09/2026. After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
Editas Medicine last reported quarterly earnings on 8/5/2026 (Q2 2026). Earnings per share (EPS) came in at -0.15 USD.
Editas Medicine has beaten analyst EPS estimates in 5 of its last 5 evaluated quarters (beat rate: 100%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.